Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy

Antiviral Therapy

Volumn 19, Issue 1, 2014, Pages 41-49

  Avihingsanon, Anchalee ^a,b   Apornpong, Tanakorn ^a   Ramautarsing, Reshmie A ^a,c   Ubolyam, Sasiwimol ^a   Tangkijvanich, Pisit ^b   Ananworanich, Jintanat ^a,b   Lange, Joep M A ^c   Matthews, Gail ^d   Lewin, Sharon R ^e,f   Ruxrungtham, Kiat ^a,b  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; TENOFOVIR DISOPROXIL;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG SAFETY; ELASTOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHOSPHATEMIA; LIVER CIRRHOSIS; LIVER FIBROSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RISK FACTOR; THAILAND; TREATMENT DURATION; TUBULAR DYSFUNCTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HIV INFECTIONS; HUMANS; HYPOPHOSPHATEMIA; KIDNEY FUNCTION TESTS; KIDNEY TUBULES, PROXIMAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS; THAILAND; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84896959225     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2673     Document Type: Article

References (47)

1. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 1996; 38 Suppl 2:S18-S23. (Pubitemid 26167500)
2. Gilson RJ, Hawkins AE, Beecham MR, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997; 11:597-606. (Pubitemid 27135881)
3. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5. (Pubitemid 27072597)
4. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19:593-601. (Pubitemid 40543982)
5. Chun HM, Fieberg AM, Hullsiek KH, et al. Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clin Infect Dis 2010; 50:426-436.
6. Law WP, Duncombe CJ, Mahanontharit A, et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 2004; 18:1169-1177. (Pubitemid 38738516)
7. Sungkanuparph S, Vibhagool A, Manosuthi W, et al. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. J Med Assoc Thai 2004; 87:1349-1354. (Pubitemid 40238559)
8. Sungkanuparph S, Wongprasit P, Manosuthi W, Atamasirikul K. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting. Southeast Asian J Trop Med Public Health 2008; 39:863-866.
9. Kiertiburanakul S, Chotiprasitsakul D, Atamasirikul K, Sungkanuparph S. Late and low compliance with hepatitis B serology screening among HIV-infected patients in a resource-limited setting: an issue to improve HIV care. Curr HIV Res 2011; 9:54-60.
10. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
11. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 97:13-19. (Pubitemid 41546209)
12. Mueller NJ, Fux CA, Ledergerber B, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010; 24:1127-1134.
13. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24:1375-1382.
14. Wasserman P, Rubin DS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDS 2010; 24:223-227.
15. Allavena C, Delpierre C, Cuzin L, et al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother 2012; 67:2222-2230.
16. Conrado T, Miranda-Filho Dde B, Ximenes RA, et al. Vitamin D deficiency in HIV-Infected women on antiretroviral therapy living in the tropics. J Int Assoc Physicians AIDS Care (Chic) 2011; 10:239-245.
17. Avihingsanon ARR, Praditpornsilpa K, Wongsabut J, et al. Prevalence of and risk factors for hypovitaminosis D among HIV-infected adults living in the tropics. 19th Conference on Retroviruses and Opportunistic Infections. 5-8 March 2012, Seattle, WA, USA. Abstract 882.
18. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010; 55:2624-2628.
19. Petta S, Camma C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51:1158-1167.
20. Terrier B, Carrat F, Geri G, et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011; 55:756-761.
21. Kumar N, Bower M, Nelson M. Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir. Int J STD AIDS 2012; 23:59-60.
22. Labarga P, Barreiro P, Martin-Carbonero L, et al. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS 2009; 23:689-696.
23. Perrot S, Aslangul E, Szwebel T, Caillat-Vigneron N, Le Jeunne C. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient. J Clin Rheumatol 2009; 15:72-74.
24. Garlassi E, Zona S, Vescini F, et al. Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV-infected women. J Int AIDS Soc 2012; 15 Suppl 4:18317.
25. Haverkort ME, van der Spek BW, Lips P, et al. Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature. Scand J Infect Dis 2011; 43:821-826.
26. Woodward CL, Hall AM, Williams IG, et al. Tenofovir-associated renal and bone toxicity. HIV Med 2009; 10:482-487.
27. Brim NM, Cu-Uvin S, Hu SL, O'Bell JW. Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome. AIDS Read 2007; 17:322-328.
28. Piso RJ, Rothen M, Rothen JP, Stahl M. Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used. J Acquir Immune Defic Syndr 2011; 56:320-324.
29. Bonjoch A, Figueras M, Estany C, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 2010; 24:2827-2833.
30. George J, Ganesh HK, Acharya S, et al. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 2009; 15:3516-3522.
31. Pasquet A, Viget N, Ajana F, et al. Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? AIDS 2011; 25:873-874.
32. Welz T, Childs K, Ibrahim F, et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24:1923-1928.
33. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526. (Pubitemid 36919874)
34. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43:1317-1325. (Pubitemid 43980111)
35. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
36. Ramautarsing RA, Tangkijvanich P, Jirajariyavej S, et al. Predictors for the presence of liver fibrosis among HCV and HIV/HCV infected patients in Thailand. 20th Conference on Retroviruses and Opportunistic Infections. 3-6 March 2013, Atlanta, GA, USA. Abstract P-121.
37. Wiboonchutikul S, Sungkanuparph S, Kiertiburanakul S, et al. Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting. J Int Assoc Physicians AIDS Care (Chic); 11:305-310.
38. Chailurkit LO, Aekplakorn W, Ongphiphadhanakul B. Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health 2011; 11:853.
39. Tang SJ AR, Schulman A, Jacobson I. Prevalence of vitamin D deficiency in patients with chronic viral hepatitis. Digestive Disease Week. 7-11 May 2011, Chicago, IL, USA. Abstract P-121.
40. van der Mei IA, Ponsonby AL, Engelsen O, et al. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 2007; 115:1132-1139. (Pubitemid 351802343)
41. Milazzo L, Mazzali C, Bestetti G, et al. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr HIV Res 2011; 9:186-193.
42. Hosseinpanah F, Pour SH, Heibatollahi M, et al. The effects of air pollution on vitamin D status in healthy women: a cross sectional study. BMC Public Health 2010; 10:519.
43. Manicourt DH, Devogelaer JP. Urban tropospheric ozone increases the prevalence of vitamin D deficiency among Belgian postmenopausal women with outdoor activities during summer. J Clin Endocrinol Metab 2008; 93:3893-3899.
44. Gara N, Zhao X, Collins MT, et al. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther 2012; 35:1317-1325.
45. Welz T, Childs K, Post FA. Do nevirapine and efavirenz affect vitamin D homeostasis similarly? AIDS 2011; 25:875-876.
46. Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52:396-405.
47. Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10:e1001383.